Literature DB >> 15216487

Role of nutrition for cardiovascular risk reduction in chronic kidney disease patients.

T Alp Ikizler1.   

Abstract

Cardiovascular disease (CVD) is the major cause of death in end-stage renal disease (ESRD) patients. Uremic malnutrition and chronic inflammation are important comorbid conditions, closely associated with CVD risk in ESRD patients. A pathophysiologic link between uremic malnutrition, chronic inflammation, and atherosclerosis has been proposed in this patient population. Uremic malnutrition can result from chronic inflammation and can accelerate the progression of cardiovascular disease. Chronic inflammation can also directly predispose ESRD patients to a proatherogenic state. Both uremic malnutrition and chronic inflammation are also associated with increased oxidative stress, a condition proposed as a unifying concept of CVD in uremia. Although a single common etiology has not been identified in this complex process, nutritional, anti-inflammatory, and antioxidant interventions can provide potential treatment options to improve the high mortality and morbidity in ESRD patients.

Entities:  

Mesh:

Year:  2004        PMID: 15216487     DOI: 10.1053/j.arrt.2004.01.008

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  2 in total

1.  A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis.

Authors:  Salvatore Santo Signorelli; Pasquale Fatuzzo; Francesco Rapisarda; Sergio Neri; Margherita Ferrante; Gea Oliveri Conti; Roberto Fallico; Luigi Di Pino; Giuseppe Pennisi; Gabriella Celotta; Anzaldi Massimiliano
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

2.  Dietary Intake of Proteins and Calories Is Inversely Associated With The Oxidation State of Plasma Thiols in End-Stage Renal Disease Patients.

Authors:  Paolo Fanti; Daniela Giustarini; Ranieri Rossi; Sue E D Cunningham; Franco Folli; Khaled Khazim; John Cornell; Elena Matteucci; Shweta Bansal
Journal:  J Ren Nutr       Date:  2015-07-31       Impact factor: 3.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.